Medical - Diagnostics & Research
Compare Stocks
4 / 10Stock Comparison
RDNT vs AMSF vs KNTK vs SMID
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Specialty
Oil & Gas Midstream
Construction Materials
RDNT vs AMSF vs KNTK vs SMID — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Diagnostics & Research | Insurance - Specialty | Oil & Gas Midstream | Construction Materials |
| Market Cap | $4.45B | $569M | $3.33B | $186M |
| Revenue (TTM) | $2.04B | $325M | $1.73B | $89M |
| Net Income (TTM) | $47M | $46M | $228M | $12M |
| Gross Margin | 11.2% | 47.6% | 24.8% | 28.0% |
| Operating Margin | 3.0% | 17.8% | 8.2% | 17.6% |
| Forward P/E | 91.8x | 14.4x | 42.4x | 24.2x |
| Total Debt | $1.86B | $491K | $3.87B | $5M |
| Cash & Equiv. | $767M | $62M | $4M | $8M |
RDNT vs AMSF vs KNTK vs SMID — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| RadNet, Inc. (RDNT) | 100 | 337.4 | +237.4% |
| AMERISAFE, Inc. (AMSF) | 100 | 49.4 | -50.6% |
| Kinetik Holdings In… (KNTK) | 100 | 702.3 | +602.3% |
| Smith-Midland Corpo… (SMID) | 100 | 729.6 | +629.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RDNT vs AMSF vs KNTK vs SMID
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RDNT lags the leaders in this set but could rank higher in a more targeted comparison.
AMSF carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
- Lower P/E (14.4x vs 24.2x)
- 14.3% margin vs RDNT's 2.3%
- Beta 0.23 vs SMID's 1.58, lower leverage
KNTK is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 3 yrs, beta 0.60, yield 16.5%
- Beta 0.60, yield 16.5%, current ratio 0.69x
- 16.5% yield, 3-year raise streak, vs AMSF's 8.4%, (2 stocks pay no dividend)
- +28.0% vs AMSF's -29.2%
SMID is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 31.8%, EPS growth 8.7%, 3Y rev CAGR 15.7%
- 14.4% 10Y total return vs RDNT's 9.5%
- 31.8% revenue growth vs AMSF's 2.6%
- 13.8% ROA vs RDNT's 1.3%, ROIC 21.2% vs 2.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.8% revenue growth vs AMSF's 2.6% | |
| Value | Lower P/E (14.4x vs 24.2x) | |
| Quality / Margins | 14.3% margin vs RDNT's 2.3% | |
| Stability / Safety | Beta 0.23 vs SMID's 1.58, lower leverage | |
| Dividends | 16.5% yield, 3-year raise streak, vs AMSF's 8.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +28.0% vs AMSF's -29.2% | |
| Efficiency (ROA) | 13.8% ROA vs RDNT's 1.3%, ROIC 21.2% vs 2.0% |
RDNT vs AMSF vs KNTK vs SMID — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
RDNT vs AMSF vs KNTK vs SMID — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMSF leads in 2 of 6 categories
SMID leads 1 • KNTK leads 1 • RDNT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMSF leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RDNT is the larger business by revenue, generating $2.0B annually — 23.0x SMID's $89M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to RDNT's 2.3%. On growth, RDNT holds the edge at +14.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.0B | $325M | $1.7B | $89M |
| EBITDAEarnings before interest/tax | $214M | $58M | $534M | $18M |
| Net IncomeAfter-tax profit | $47M | $46M | $228M | $12M |
| Free Cash FlowCash after capex | -$178M | $8M | $441M | $5M |
| Gross MarginGross profit ÷ Revenue | +11.2% | +47.6% | +24.8% | +28.0% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +17.8% | +8.2% | +17.6% |
| Net MarginNet income ÷ Revenue | +2.3% | +14.3% | +13.2% | +13.2% |
| FCF MarginFCF ÷ Revenue | -8.7% | +2.5% | +25.5% | +5.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.8% | +10.3% | -7.5% | -9.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -114.1% | -8.5% | -2.4% | -8.5% |
Valuation Metrics
AMSF leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, AMSF trades at a 49% valuation discount to SMID's 24.2x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than RDNT's 25.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $4.5B | $569M | $3.3B | $186M |
| Enterprise ValueMkt cap + debt − cash | $5.5B | $508M | $7.2B | $183M |
| Trailing P/EPrice ÷ TTM EPS | -230.00x | 12.27x | 18.43x | 24.15x |
| Forward P/EPrice ÷ next-FY EPS est. | 91.75x | 14.42x | 42.44x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.79x |
| EV / EBITDAEnterprise value multiple | 25.88x | 8.53x | 13.14x | 14.60x |
| Price / SalesMarket cap ÷ Revenue | 2.18x | 1.80x | 1.89x | 2.37x |
| Price / BookPrice ÷ Book value/share | 3.19x | 2.30x | 1.04x | 4.45x |
| Price / FCFMarket cap ÷ FCF | 52.01x | 63.83x | 44.78x | — |
Profitability & Efficiency
Evenly matched — AMSF and SMID each lead in 5 of 9 comparable metrics.
Profitability & Efficiency
SMID delivers a 22.6% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $4 for RDNT. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to RDNT's 1.37x. On the Piotroski fundamental quality scale (0–9), AMSF scores 7/9 vs KNTK's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.8% | +9.7% | +21.1% | +22.6% |
| ROA (TTM)Return on assets | +1.3% | +5.6% | +4.2% | +13.8% |
| ROICReturn on invested capital | +2.0% | +21.9% | +1.9% | +21.2% |
| ROCEReturn on capital employed | +2.1% | +16.8% | +2.5% | +20.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 4 | 7 |
| Debt / EquityFinancial leverage | 1.37x | 0.00x | 1.32x | 0.12x |
| Net DebtTotal debt minus cash | $1.1B | -$61M | $3.9B | -$2M |
| Cash & Equiv.Liquid assets | $767M | $62M | $4M | $8M |
| Total DebtShort + long-term debt | $1.9B | $491,000 | $3.9B | $5M |
| Interest CoverageEBIT ÷ Interest expense | 1.46x | — | 5.98x | 72.70x |
Total Returns (Dividends Reinvested)
SMID leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SMID five years ago would be worth $26,938 today (with dividends reinvested), compared to $8,110 for AMSF. Over the past 12 months, KNTK leads with a +28.0% total return vs AMSF's -29.2%. The 3-year compound annual growth rate (CAGR) favors SMID at 29.0% vs AMSF's -9.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -19.0% | -18.3% | +37.4% | -6.6% |
| 1-Year ReturnPast 12 months | +4.6% | -29.2% | +28.0% | +14.2% |
| 3-Year ReturnCumulative with dividends | +100.0% | -24.8% | +93.9% | +114.7% |
| 5-Year ReturnCumulative with dividends | +147.1% | -18.9% | +93.1% | +169.4% |
| 10-Year ReturnCumulative with dividends | +947.4% | +31.8% | -33.5% | +1436.8% |
| CAGR (3Y)Annualised 3-year return | +26.0% | -9.1% | +24.7% | +29.0% |
Risk & Volatility
Evenly matched — AMSF and KNTK each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than SMID's 1.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KNTK currently trades 94.8% from its 52-week high vs AMSF's 62.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.43x | 0.23x | 0.60x | 1.58x |
| 52-Week HighHighest price in past year | $85.84 | $48.54 | $51.11 | $43.66 |
| 52-Week LowLowest price in past year | $50.76 | $29.42 | $31.33 | $25.56 |
| % of 52W HighCurrent price vs 52-week peak | +67.0% | +62.4% | +94.8% | +80.2% |
| RSI (14)Momentum oscillator 0–100 | 51.3 | 34.2 | 51.3 | 58.1 |
| Avg Volume (50D)Average daily shares traded | 822K | 212K | 1.2M | 9K |
Analyst Outlook
KNTK leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: RDNT as "Buy", AMSF as "Buy", KNTK as "Buy". Consensus price targets imply 60.0% upside for RDNT (target: $92) vs -1.8% for KNTK (target: $48). For income investors, KNTK offers the higher dividend yield at 16.47% vs AMSF's 8.41%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | — |
| Price TargetConsensus 12-month target | $92.00 | $44.50 | $47.57 | — |
| # AnalystsCovering analysts | 11 | 6 | 15 | — |
| Dividend YieldAnnual dividend ÷ price | — | +8.4% | +16.5% | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | 3 | 0 |
| Dividend / ShareAnnual DPS | — | $2.55 | $7.98 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.1% | +5.3% | 0.0% |
AMSF leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). SMID leads in 1 (Total Returns). 2 tied.
RDNT vs AMSF vs KNTK vs SMID: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RDNT or AMSF or KNTK or SMID a better buy right now?
For growth investors, Smith-Midland Corporation (SMID) is the stronger pick with 31.
8% revenue growth year-over-year, versus 2. 6% for AMERISAFE, Inc. (AMSF). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate RadNet, Inc. (RDNT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RDNT or AMSF or KNTK or SMID?
On trailing P/E, AMERISAFE, Inc.
(AMSF) is the cheapest at 12. 3x versus Smith-Midland Corporation at 24. 2x. On forward P/E, AMERISAFE, Inc. is actually cheaper at 14. 4x.
03Which is the better long-term investment — RDNT or AMSF or KNTK or SMID?
Over the past 5 years, Smith-Midland Corporation (SMID) delivered a total return of +169.
4%, compared to -18. 9% for AMERISAFE, Inc. (AMSF). Over 10 years, the gap is even starker: SMID returned +1437% versus KNTK's -33. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RDNT or AMSF or KNTK or SMID?
By beta (market sensitivity over 5 years), AMERISAFE, Inc.
(AMSF) is the lower-risk stock at 0. 23β versus Smith-Midland Corporation's 1. 58β — meaning SMID is approximately 583% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 137% for RadNet, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RDNT or AMSF or KNTK or SMID?
By revenue growth (latest reported year), Smith-Midland Corporation (SMID) is pulling ahead at 31.
8% versus 2. 6% for AMERISAFE, Inc. (AMSF). On earnings-per-share growth, the picture is similar: Smith-Midland Corporation grew EPS 866. 7% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, SMID leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RDNT or AMSF or KNTK or SMID?
AMERISAFE, Inc.
(AMSF) is the more profitable company, earning 14. 9% net margin versus 2. 3% for RadNet, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 3. 0% for RDNT. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RDNT or AMSF or KNTK or SMID more undervalued right now?
On forward earnings alone, AMERISAFE, Inc.
(AMSF) trades at 14. 4x forward P/E versus 91. 8x for RadNet, Inc. — 77. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RDNT: 60. 0% to $92. 00.
08Which pays a better dividend — RDNT or AMSF or KNTK or SMID?
In this comparison, KNTK (16.
5% yield), AMSF (8. 4% yield) pay a dividend. RDNT, SMID do not pay a meaningful dividend and should not be held primarily for income.
09Is RDNT or AMSF or KNTK or SMID better for a retirement portfolio?
For long-horizon retirement investors, AMERISAFE, Inc.
(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 8%, RDNT: +947. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RDNT and AMSF and KNTK and SMID?
These companies operate in different sectors (RDNT (Healthcare) and AMSF (Financial Services) and KNTK (Energy) and SMID (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RDNT is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock; KNTK is a small-cap high-growth stock; SMID is a small-cap high-growth stock. AMSF, KNTK pay a dividend while RDNT, SMID do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.